| 摘要 |
<p>The present invention provides antigenic and immunogenic peptides prepared by the proteolysis of human cytomegalovirus (HCMV) glycoprotein complex I (gc-I) which peptides can be used as the active ingredient in anti-HCMV vaccines, to detect anti-HCMV antibodies or to proliferate HCMV-specific T cells.</p> |
